AFT's product portfolio comprises both proprietary and in-licensed products, and includes patented, branded and generic drugs.
(NYSE:AFT) is a closed-end fund that seeks current income and preservation of capital by investing primarily in senior, secured loans to companies rated below ...
Investor Menu. Overview · Share Info · Results Centre · Analyst ... Shares in AFT Pharmaceuticals Limited (“AFT ... Annual Report - FY2021Opens in new window · FY21 ...
AFT Holdings portfolio represents the largest US shareholder of the leading US Flag tuna fleet based in the Western Pacific, as well as the primary investor ...
People also ask
Who owns AFT Pharmaceuticals?
What does AFT Pharmaceuticals do?
Who is Hartley Atkinson?
What is the annual revenue of AFT Pharmaceuticals?
INVESTORS AND POLICYMAKERS AFT 13. Outside of the immediate investment management relationship, institutional investors may also face indirect risks.
Managing the State's cash requirements. Agence France Trésor (AFT) manages the State's cash requirements so that it can meet its financial commitments at all ...
Access information about our recent and historical financial performance, dividend declarations, conference appearances and other noteworthy developments.
Find the latest Apollo Senior Floating Rate Fund Inc. (AFT) stock quote, history, news and other vital information to help you with your stock trading and ...
Missing: investor relations
This information can be used by investors to verify and understand the financial position of the company. Many, but not all SEC filings are available in the ...
Incorporated in New Zealand ARBN: ARBN 609 017 969 investor.relations@aftpharm.com. 9 January 2024. NEW YEAR LETTER TO INVESTORS. AFT poised to accelerate ...
